Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00262-012-1347-9PMID 22986452PMCID PMC11028855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers in the selection of maintenance therapy in non-small cell lung cancer.

  2012cited by this paper
• Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review.

  2012cited by this paper
• Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal Cancer

  2012cited by this paper
• Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

  2012cited by this paper
• Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy

  2012cited by this paper
• Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.

  2012cited by this paper
• The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma.

  2012cited by this paper
• Prognostic Immune Markers in Non–Small Cell Lung Cancer

  2011cited by this paper
• Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer.

  2011cited by this paper
• Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer

  2011cited by this paper
• Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer.

  2011cited by this paper
• Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients

  2011cited by this paper
• Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection

  2010cited by this paper
• Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy

  2009cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.

  2009cited by this paper
• The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer

  2008cited by this paper
• Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment

  2008cited by this paper
• Effects of Gender on White Blood Cell Populations and Neutrophil-Lymphocyte Ratio Following Gastrectomy in Patients with Stomach Cancer

  2007cited by this paper
• Prognostic factors in patients with inoperable non-small cell lung cancer--an analysis of long-term survival patients.

  2006cited by this paper
• Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer

  2005cited by this paper
• Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

  1991cited by this paper

• Clinical Characteristics and Spatial Transcriptome Analysis of Non–Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study

  2026influential citation
• Predicting the prognosis of patients with lung adenocarcinoma treated with third-generation EGFR-TKI alone using nomograms based on CT radiomic and clinicopathological factors

  2025cites this paper
• The Clinical Role of Systemic Inflammation-Based Biomarkers in Predicting Mortality in Post-Pneumonectomy Bronchopleural Fistula: A Multicenter Retrospective Analysis

  2025cites this paper
• Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microenvironment in pancreatic cancer: a retrospective cohort study

  2025cites this paper
• Long-term oncological outcomes and recurrence patterns after segmentectomy for early-stage non-small cell lung cancer: A dual-center retrospective study.

  2025cites this paper
• Long-term survival with pemetrexed-based chemotherapy in a patient with metastatic lung adenocarcinoma of unclear primary origin harboring MTHFR C677T(T/T) mutation: a case report

  2025cites this paper
• Prognostic Value of Systemic Immune Inflammation Index in Squamous Cell Lung Cancer

  2025cites this paper
• Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in non-small cell lung cancer: a meta-analysis

  2025cites this paper
• Machine learning driven prediction of drug efficacy in lung cancer: Based on protein biomarkers and clinical features.

  2025cites this paper
• Complete blood count parameters as potential predictive factors of brain metastases in lung cancer

  2025cites this paper
• The Current State of Tumor Microenvironment-Specific Therapies for Non-Small Cell Lung Cancer

  2025cites this paper
• Neutrophil-to-lymphocyte ratio and its association with latent tuberculosis infection and all-cause mortality in the US adult population: a cohort study from NHANES 2011–2012

  2024cites this paper
• Overview of The Neutrophil-Lymphocyte Ration (NLR) as a Prognosis Biomarker of Non-Small Cell Lung Cancer (NSCLC)

  2024cites this paper
• Baseline and early dynamic changes in inflammatory and nutritional status can predict survival in patients with advanced biliary tract carcinoma receiving immunotherapy: A retrospective cohort study

  2024cites this paper
• The Correlation of Neutrophil-Lymphocyte Ratio (NLR) and the Response Evaluation Criteria in Solid Tumors (RECIST) in Non-small Cell Lung Cancer (NSCLC) Patient

  2024cites this paper
• Comparison of the Clinical Features and Prognostic Value of Inflammation-Based Markers in Uterine Leiomyosarcoma

  2024cites this paper
• Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy

  2024cites this paper
• Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer

  2024cites this paper
• Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer

  2024cites this paper
• Prognostic value of diffuse cancer inflammation index (ALI), serum neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) in advanced-stage lung cancer.

  2023cites this paper
• NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps.

  2023cites this paper
• The contribution of neutrophil-lymphocyte ratio on prognosis in patients diagnosed with epidermal growth factor receptor mutant lung adenocarcinoma

  2023cites this paper
• Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients

  2023cites this paper
• Dynamic change of the systemic immune inflammation index is a risk factor for patients with oropharyngeal cancer: a case control study and an additional HPV-status subgroup analysis

  2023cites this paper
• Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy

  2023cites this paper
• Impact of Immuno-nutritional status (prognostic nutritional index, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio) on response to Transarterial chemoembolization in Patients with Hepatocellular carcinoma

  2023cites this paper
• Nanotechnology: A New Strategy for Lung Cancer Treatment Targeting Pro-Tumor Neutrophils

  2022cites this paper
• Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib

  2022cites this paper
• Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study

  2022cites this paper
• Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study

  2022cites this paper
• Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial

  2022cites this paper
• Clinical value of serum albumin level in patients with non-small cell lung cancer and anaplastic lymphoma kinase (ALK) rearrangement.

  2021cites this paper
• Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors

  2021cites this paper
• Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion

  2021cites this paper
• Relationships between Vitamin D and Selected Cytokines and Hemogram Parameters in Professional Football Players—Pilot Study

  2021cites this paper
• Preoperative Prognostic Nutrition Index as a Prognostic Indicator of Survival in Elderly Patients Undergoing Gastric Cancer Surgery

  2021cites this paper
• Neutrophil-to-lymphocyte ratio predicts prognosis of patients with hepatocellular carcinoma: a systematic review and meta-analysis

  2021cites this paper
• Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.

  2021cites this paper
• Prognostic Value of Diffuse Cancer Inflammation Index (ALI), Serum Neutrophil/Lymphocyte Ratio (NLR) and Platelet/lymphocyte Ratio (PLR) in Advanced Stage Lung Cancer İleri Evre Akciğer Kanserinde; Yaygın Kanser İnflamasyon İndeksi (ALI), Serum Nötrofil/Lenfosit Oranı (NLR), Trombosit/Lenfosit Oranı

  2021cites this paper
• Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated With Early Disease Progression in Stage IV Non-small Cell Lung Cancer

  2020cites this paper
• Preoperative systemic inflammatory biomarkers and postoperative day 1 drain amylase value predict grade C pancreatic fistula after pancreaticoduodenectomy

  2020cites this paper
• Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment

  2020cites this paper
• Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer.

  2020cites this paper
• Relationship between dynamic monitoring NLR and PLR,and efficacy of first鄄line chemotherapy and prognosis of advanced lung adenocarcinoma

  2020cites this paper
• Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical Outcomes

  2020cites this paper
• Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of patients with hepatocellular: A systematic review and meta-analysis

  2020cites this paper
• Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy

  2020cites this paper
• Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy

  2020cites this paper
• Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer

  2020cites this paper
• Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

  2020cites this paper
• High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study

  2020cites this paper
• Kobe University Repository : Kernel タイトル Tit le The t ime-series behavior of neutrophil-to-lymphocyte rat io is useful as a predict ive marker in non-small cell lung cancer

  2019cites this paper
• Blood neutrophil-to-lymphocyte ratio as a predictor of response to chemotherapy in head-and-neck cancers

  2019cites this paper
• Changes in total lymphocyte count and neutrophil‐to‐lymphocyte ratio after curative pancreatectomy in patients with pancreas adenocarcinoma and their prognostic role

  2019cites this paper
• Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer.

  2019cites this paper
• Are Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Associated with Mortality in Pediatric Trauma Patients? A Retrospective Study

  2019cites this paper
• Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations

  2019cites this paper
• OTT_A_225544 8779..8787

  2019cites this paper
• Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review.

  2019cites this paper
• Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at the time of diagnosis

  2019cites this paper
• Neutrophil lymphocyte ratio is an independent prognosticator in patients with locally advanced head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil

  2019cites this paper
• Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy.

  2019cites this paper
• EVALUATION OF THE EARLY PROGNOSTIC VALUE OF NEUTROPHIL-LYMPHOCYTE RATIO (NLR) AND PLATELET-LYMPHOCYTE RATIO (PLR) IN SNAKEBITE POISONED PATIENTS

  2019cites this paper
• Lymphopenia predicts response to stereotactic radiosurgery in lung cancer patients with brain metastases

  2019cites this paper
• Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC.

  2019cites this paper
• Effect of COPD on Inflammation, Lymphoid Functions and Progression-Free Survival during First-Line Chemotherapy in Advanced Non-small Cell Lung Cancer

  2019cites this paper
• Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung Cancer.

  2019cites this paper
• Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis

  2019cites this paper
• Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Lung Cancer

  2019cites this paper
• Cisplatin or carboplatin? Neutrophil to lymphocyte ratio may serve as a useful factor in small cell lung cancer therapy selection.

  2019cites this paper
• Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.

  2019cites this paper
• Prognostic role of neutrophil‐to‐lymphocyte ratio on esophageal cancer patients who received definitive chemoradiotherapy

  2018cites this paper
• The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI

  2018cites this paper
• Metal Drugs and the Anticancer Immune Response.

  2018cites this paper
• The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy.

  2018cites this paper
• Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy

  2018cites this paper
• 治疗前后NLR和PLR对进展期非小细胞肺癌一线化疗疗效及预后的预测价值

  2018cites this paper
• Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion

  2018cites this paper
• Effect of scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on neutrophil-to-lymphocyte ratio and quality of life in patients with non-small-cell lung cancer: A randomized, controlled trial.

  2018cites this paper
• High blood neutrophil-lymphocyte ratio associated with poor outcomes in miliary tuberculosis.

  2018cites this paper
• The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer

  2018cites this paper
• Combination of long noncoding RNA MALAT1 and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer

  2018cites this paper
• The Inflammation-Based Index Can Predict Response and Improve Patient Selection in NETs Treated With PRRT: A Pilot Study

  2018cites this paper
• Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer.

  2018cites this paper
• Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer

  2018cites this paper
• Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy

  2018cites this paper
• Significance of Neutrophil-to-lymphocyte Ratio in Western Advanced EGFR-mutated Non-small Cell Lung Cancer Receiving a Targeted Therapy

  2017cites this paper
• Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer

  2017cites this paper
• Association of the postoperative white blood cells (WBC) count in peripheral blood after radical surgical treatment of left upper lobe non-small cell lung cancer (NSCLC) with overall survival - single center results.

  2017cites this paper
• Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis

  2017cites this paper
• Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

  2017cites this paper
• Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study

  2017cites this paper
• Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet

  2017cites this paper
• Are There Relationships between Seminal Parameters and the Neutrophil-to-Lymphocyte Ratio or the Platelet-to-Lymphocyte Ratio?

  2017cites this paper
• Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions

  2017cites this paper
• Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

  2017cites this paper
• Clinical outcomes in patients with advanced epidermal growth factor receptor‐mutated non‐small‐cell lung cancer in South Western Sydney Local Health District

  2017cites this paper
• Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study

  2017cites this paper
• Prognostic significance of systemic inflammatory response in stage II colorectal cancer.

  2017cites this paper
• Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection

  2017cites this paper